Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma
EJC Skin Cancer · 2026 · 4 · 100962
DOI: 10.1016/j.ejcskn.2026.100962 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von D. Rischin und 30 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rischin, D., Chen, C., Porceddu, S., Day, F., Brungs, D., Christie, H., Jackson, J., Stein, B., Su, Y., Ladwa, R., Bowyer, S., Otty, Z., Yamazaki, N., Bossi, P., Challapalli, A., Hauschild, A., Schurman, M. D. L. V., Queirolo, P., Cañueto, J., …, & Lim, A. (2026). Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma. EJC Skin Cancer, 4, 100962. https://doi.org/10.1016/j.ejcskn.2026.100962
Vancouver
Rischin D, Chen C, Porceddu S, Day F, Brungs D, Christie H, et al. Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma. EJC Skin Cancer. 2026;4:100962. doi:10.1016/j.ejcskn.2026.100962
BibTeX
@article{Rischin2026,
author = {Rischin, D. and Chen, C.-I. and Porceddu, S. and Day, F. and Brungs, D.P. and Christie, H. and Jackson, J.E. and Stein, B.N. and Su, Y.B. and Ladwa, R. and Bowyer, S.E. and Otty, Z. and Yamazaki, N. and Bossi, P. and Challapalli, A. and Hauschild, A. and Schurman, M. De Liz Vassen and Queirolo, P. and Cañueto, J. and Silva, F.A. Ferreira da and Stratigos, A. and Guminski, A. and Bansal, S. and Joseph, C. and Seebach, F. and Yoo, S.-Y. and Harnett, J. and Chi, L. and Goncalves, P. and Fury, M.G. and Lim, A.M.},
title = {Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {100962},
doi = {10.1016/j.ejcskn.2026.100962}
}
EUVIMED